INTRODUCTION
Children presenting with cough and other symptoms of respiratory tract infection (RTI) are the most frequent attenders to general practice internationally, are almost all managed in primary care, and the majority still receive antibiotics. 1-3 A very small percentage of children are hospitalised for serious bacterial illnesses or complications. 4, 5 However, GPs are risk averse and report prescribing antibiotics at the point of presentation to this patient group 'just in case' 6, 7 and in fear of a poor outcome. [6] [7] [8] [9] This uncertainty is fuelled by the very limited experimental or observational evidence available regarding the impact of different antibiotic prescribing strategies on major adverse outcomes among children. Available systematic reviews suggest that antibiotics have limited efficacy in treating a large proportion of upper RTIs [10] [11] [12] [13] but the reviews are underpowered to assess complications and there is little evidence for bronchitis, in particular. Although there is some evidence for adults, [14] [15] [16] [17] [18] [19] there is almost no meaningful evidence in children regarding complications if antibiotics are withheld for respiratory infections. The major problem with continuing to prescribe for respiratory infections in children is that primary care antibiotic use is a major driver of antibiotic resistance internationally. 20 Two large prospective cohort studies of adults with RTI symptoms demonstrated that either immediate or delayed antibiotic prescriptions can modify health outcomes. 18, 19 The authors were aware of no comparable data in children. This paper used data from a large cohort study to establish whether an immediate or delayed antibiotic prescription given to children with acute cough and RTI in primary care modifies risk of subsequent hospitalisation or reconsultation with deterioration.
METHOD
A large, four-centre (England, UK) prospective cohort study was conducted that recruited children aged 3 months to <16 years presenting to primary care with acute cough and RTI between July 2011
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Aim
To estimate the effect of children's antibiotic prescribing on adverse outcomes within 30 days of initial consultation.
Design and setting
Secondary analysis of 8320 children in a multicentre prospective cohort study, aged 3 months to <16 years, presenting in primary care across England with acute cough and other respiratory symptoms.
Method
Baseline clinical characteristics and antibiotic prescribing data were collected, and generalised linear models were used to estimate the effect of antibiotic prescribing on adverse outcomes within 30 days (subsequent hospitalisations and reconsultation for deterioration), controlling for clustering and clinicians' propensity to prescribe antibiotics.
Results
Sixty-five (0.8%) children were hospitalised and 350 (4%) reconsulted for deterioration. Clinicians prescribed immediate and delayed antibiotics to 2313 (28%) and 771 (9%), respectively. Compared with no antibiotics, there was no clear evidence that antibiotics reduced hospitalisations (immediate antibiotic risk ratio [RR] 0.83, 95% confidence interval [CI] = 0.47 to 1.45; delayed RR 0.70, 95% CI = 0.26 to 1.90, overall P = 0.44). There was evidence that delayed (rather than immediate) antibiotics reduced reconsultations for deterioration (immediate RR 0.82, 95% CI = 0.65 to 1.07; delayed RR 0.55, 95% CI = 0.34 to 0.88, overall P = 0.024). and May 2013. The results from the primary aim of the study have been published. 5 Here are presented findings from a secondary analysis.
The protocol has been described elsewhere. 21 In summary, eligible children presenting to primary care were recruited by prescribing 'clinicians' (GPs and prescribing practice nurses) across four centres if they presented with acute cough as the most prominent symptom, combined with other symptoms or signs suggestive of RTI. Clinicians who self-reported prescribing antibiotics in ≤30% to children with RTIs were invited to participate. Following informed consent, clinicians completed a structured case report form (Appendix 1) that included sociodemographics, parentreported symptoms, clinician-assessed signs, diagnosis, and whether an immediate or delayed antibiotic was prescribed (including number of days delayed) at the time of the consultation.
The main outcomes, hospitalisation for any RTI in the 30 days following recruitment and reconsultation for deterioration (a proxy marker for reconsultation for the same episode of RTI illness with evidence of worsening illness, shown to be reliably assessed), 22 were collected via a detailed review of the child's medical record. History of chronic conditions was also recorded. Medical record reviews were generally conducted 3 months post-recruitment for each child, to allow for adequate feedback to occur. On some occasions this was slightly longer than 3 months, and in all cases the period of time was sufficient to allow both reconsultations and complications to occur. Double, independent medical record review was undertaken in a random set of 1% of participants to estimate inter-reviewer error.
Data preparation
Children referred for acute hospitalisation at the consultation were excluded from the analysis, as clinicians' prescribing behaviour was expected to differ for children whom they had decided to refer to hospital on the same day as the consultation, compared with those they did not.
Common clinical cut-offs were used for continuous data where possible (high temperature >37.8°C) 23 and were agerelated if appropriate (age-specific heart and respiratory rates and blood pressure). 24 UK guidelines for low oxygen saturation level (≤95%) were used. 25 Given the large number of variables, continuous variables were dichotomised using 25 th or 75 th percentile cut-offs as appropriate. For carer-reported symptom severity (mild, moderate, or severe) in the 24 hours prior to consultation, dichotomy for each variable was split, depending on the overall prevalence, to either 'severe' if more than 5% of the whole cohort fell into this category or 'moderate and severe' if the proportion was smaller. This pragmatic cut-off was chosen prior to analysis to avoid variables with very low prevalence. Capillary refill time (CRT) was coded as normal (≤2 seconds) or long (≥3 seconds). 26, 27 Multiple deprivation score was based on the family postcode using the UK Indices of Multiple Deprivation 2007. 28
Covariates
Variables measured at the baseline consultation (symptoms, signs, demographics) were identified as possible confounders/covariates. These variables were considered during the analysis of secondary outcomes (Appendix 2).
Statistical analysis
All data were analysed using STATA (version 13.1). The κ statistic to assess inter-rater reliability of the two main outcomes was calculated. Generalised linear modelling with a log link to produce risk ratios (RR) was used, accounting for clustering by clinician and controlling for potential covariates associated with the prescription strategy and the two outcomes. Two models were generated: in the first, variables were selected using backward stepwise selection with variables retained if the P-value <0.05. In the second model, analyses were conducted post-hoc, where a stratified propensity score was created, which allowed for more rigorous control of potential confounding by indication. 29, 30 How this fits in Antibiotic prescribing to children in primary care is one of the key areas of inappropriate prescribing. This is mainly due to the lack of evidence for, and uncertainty regarding, which children are at risk of poor outcome. This study investigated whether antibiotic prescribing had an impact on two adverse health outcomes for children: hospitalisation for respiratory tract infections and reconsultation for deteriorating symptoms. The study shows that there is little evidence to justify the use of antibiotics for reducing hospitalisation, which occurred very rarely, and supports previous research in adults that a delayed antibiotic prescribing strategy is likely to reduce reconsultation for deterioration.
RESULTS

Ascertainment and baseline characteristics
Between July 2011 and May 2013, 518 clinicians recruited children from 247 primary care practices across England. A total of 8613 children were recruited, and, of these, 219 (3%) children were excluded: 181 did not meet eligibility, 32 children did not have baseline data, and six children were withdrawn. Seventy-four children referred for acute hospital admission on the day of recruitment were excluded from the analysis, leaving a total of 8320 children. Antibiotic prescription data from the baseline consultation were available for 100% of these children and all analyses used this final sample of 8320. Figure 1 details the flow of participants through the study. The outcome of hospitalisation was obtained for 8320 (100%) children, and reconsultation for deterioration was obtained for 98% (n = 8136/8320).
Inter-reviewer agreement analysis for medical record data collection was assessed. For hospitalisation this was 90% (κ 0.80) and 84% for reconsultation within r the same episode of illness (κ 0.67). Missing data for candidate predictors were infrequent (<2%) with the exception of oxygen saturation (50% missing values) due to lack of available paediatric monitors.
Clinicians prescribed antibiotics for 3084/8320 children (37%), with 2313 (28%) children prescribed immediate and 771 (9%) delayed antibiotics. The range of days the prescription was delayed for was between 0-10, median 2 (interquartile range [IQR] 2-3).
Of the 8320 children included in the analysis, 65 (0.8%) were hospitalised for an RTI in the 30 days following recruitment. Median time to hospitalisation was 4 days (IQR 1-15) with 5% hospitalised on the day of recruitment (day 0), 52% on days 1-7, 17% on days 8-14, and 26% on days 15-30. Of the 65 children hospitalised, 25 (38.5%) had been prescribed an antibiotic.
The most common RTI discharge diagnoses (Table 1) were bronchiolitis (20%), lower RTI (14%), and upper RTI (12%); other diagnoses included viral wheeze, exacerbation of asthma, tonsillitis, croup, unspecified viral illness, chest infection, bronchiolitis and bronchitis, viral pneumonitis, pyrexia, and febrile convulsions.
Just over one-fifth (22.5%; 1830/8136) of children reconsulted for any RTI symptoms in the 30 days after consultation, 14% (1163/8136) reconsulted for the same episode of RTI illness, and 4% (350/8136) reconsulted for the same RTI with evidence in their medical records of deteriorating symptoms.
Appendix 3 shows the clinical history, sociodemographics, parent/carer-reported symptoms, clinical signs observed by the clinician, and adverse health outcomes (in the 30 days post-baseline) for the children with different antibiotic strategies at the baseline consultation. There is wide variation in the number of children prescribed an immediate, delayed, or no antibiotic with regard to parent-reported symptoms and clinical signs. Not invited to participate (n = 224) Clinician too busy to use agreed recruitment strategy (n = 85); child not unwell enough (n = 24); child too unwell (n = 9); clinician forgot to ask (n = 5); miscellaneous including: already recruited, other child in the study, uncooperative patient/carer/child, child anxious/upset, did not attend with a carer, language barrier, clinician did not recruit the child fully, child meets exclusion criteria or not eligible patients, computer too slow, child already on antibiotics, learning disabilities, run out of recruitment packs (n = 101) Invitation declined (n = 164) Parent/carer thought study would take too much time (n = 54); miscellaneous reasons including: perceived difficulties with completing symptom diary, language barriers, another child already recruited, person attending with child was not carer, concerns about access to medical records, child had complex needs (n = 45); no reason given (n = 41); parent not interested (n = 22); parent thought child too ill (n = 2)
Consent form not received or not valid (n = 266)
Excluded by research team (n = 213) Child previously entered study (n = 77); immunocompromised (n = 34); child out of age range (n = 34); no baseline data (n = 32); illness duration >28 days (n = 31); temporary resident at practice (n = 3); routine swab taken (n = 1); child's date of birth not validated (n = 1)
Withdrawn by parent (n = 6) No reason (n = 3); demographic data collected too intrusive (n = 1); parent/carer did not like study having identifiable information about child (n = 1); family moved house (n = 1)
Withdrawn from analysis (n = 74) Referred for acute admission on the day of recruitment (74)
Available for analysis (n = 8320) (99% of full dataset) 
Relationships between baseline characteristics and health outcomes
Hospitalisation. Table 1 shows the discharge diagnoses for the hospitalised children and whether they received an antibiotic or not. There was no evidence of a difference between hospital diagnoses in children prescribed an antibiotic compared with those who were not (χ 2 test: P = 0.46). Table 2 details the univariable and multivariable relationships between antibiotic prescribing at the baseline consultation and subsequent hospitalisation. There was no clear evidence at the univariable level or multivariable level that prescribing immediate or delayed antibiotics reduced the risk of a child being hospitalised in the 30 days postbaseline consultation (immediate RR 0.83, 95% confidence interval [CI] = 0.47 to 1.45; delayed RR 0.70, 95% CI = 0.26 to 1.90, overall P = 0.44).
Reconsultation within 30 days for deterioration. Table 3 describes the univariable and multivariable relationships between prescription at the baseline consultation and reconsultation for deterioration. Both univariable and multivariable analysis, accounting for clinician clustering, indicate there is evidence to suggest a difference in those reconsulting with deteriorating symptoms in the subsequent 30 days, for those prescribed an antibiotic compared with those who were not (immediate RR 0.82, CI = 0.65 to 1.07; delayed RR 0.55, CI = 0.34 to 0.88, overall P = 0.02). Delayed antibiotics reduced reconsultation with deterioration by almost half and, although the point estimate for those prescribed immediate antibiotics suggests a reduction, the 95% CI means the absence of an effect cannot be ruled out.
DISCUSSION Summary
This is the first cohort evidence available to date to indicate that prescribing immediate or delayed antibiotics in children does not prevent RTI-related hospitalisation in the 30 days post primary care consultation. Hospital admissions in the 30 days after the baseline consultation were rare and almost none of the reasons for admission were related to the withholding of antibiotics. This has demonstrated that delayed antibiotics reduced the risk of the child reconsulting for the same illness with deterioration. For those given immediate antibiotics, the trend was in the same direction, although no clear evidence was found; it is not clear if this is due to a lack of power or a true finding. This supports previous research in adults that also suggests delayed prescribing should be considered if an antibiotic is being prescribed.
Strengths and limitations
The study's large observational dataset reflects a realistic primary care setting and the findings are likely to be generalisable to general practice in other high-income countries. Follow-up and case ascertainment were high. The study has several potential limitations. First, prescribing rates were relatively low in this cohort, particularly delayed prescribing, which may impact on the generalisability. The low prescribing rates are likely to be because clinicians who self-classified themselves as 'low prescribers' were eligible to recruit to the study. Second, establishing whether prescribed antibiotics were dispensed and consumed was not possible, although previous studies suggest that immediate prescriptions commonly are consumed. 31 Third, both health outcomes were rare and event rates low (as expected), particularly hospitalisation, which unavoidably limits analytic power. Fourth, as with any secondary analysis of observational data there may be residual confounding, although only a few variables predicted hospitalisation, which lessens any effect of confounding by indication. For reconsulting for deterioration, very little change in risk ratios were recorded when a wide range of potential covariates were included in the model, which suggests that confounding, for those variables that were recorded, was not a major issue.
Comparison with existing literature
The authors did not find evidence to support the use of an immediate antibiotic prescription as a means of clearly reducing hospitalisations for RTIs. Even if the lower confidence intervals for the estimate are taken, more than 200 children would need to be given an immediate antibiotic for one hospitalisation to be prevented. These findings are in agreement with evidence from systematic reviews [11] [12] [13] 32 where little or no evidence was found to support their use in children or adults. The authors found similar estimates for reconsultations for deterioration with that of one large cohort study investigating new or non-resolving symptoms in adult sore throat. 18, 19 Similarly, this evidence supports the idea that a delayed antibiotic script is not necessarily equivalent to a 'no prescription' strategy and can be a useful means to reduce reconsultations 18, 19, 33, 34 as well as the use of antibiotics. 31,33-36 Evidence from this cohort demonstrated which symptoms and signs predict complications in children presenting to general practice with acute cough and RTI. 5 This may reduce uncertainty around distinguishing which children might benefit from antibiotics, from those who are at a much lower risk of poor health outcomes where the clinician can safely make a 'no prescription' decision. 21 However, a multifaceted approach and more complex behavioural interventions may be required to support clinicians to reduce their prescribing to children. [37] [38] [39] Qualitative evidence suggests that the relationship between parents and clinicians, in relation to antibiotic prescribing for their child's RTI, is complex. Studies show that clinicians are prescribing 'just in case', 6 feel uncertain about prognostic outcomes, 7 and perceive pressure from parents to prescribe when parents want symptomatic relief and safety-netting advice. 40 prescription reduces the likelihood of a parent reconsulting with their child with deterioration. The reasons for this are not entirely clear, but may represent the timely access to antibiotics if illness is not settling, or prompt treatment of a secondary bacterial infection following an initial viral infection.
Table 3. Association between children's antibiotic prescription strategies and reconsulting for the same RTI illness with evidence of deterioration in the 30 days following the baseline consultation
Implications for practice
These findings suggest that there is little evidence that antibiotics substantially reduce the risk of hospitalisation in children presenting to primary care; and that these risks are extremely low for the majority of children presenting with acute cough and RTI. The rates of prescribing in this cohort, even for self-classified 'low prescribers', indicate continued need for interventions and strategies to better target antibiotics. These results provide reassurance that, when faced with a child and uncertain prognosis, delayed prescribing can be a safe and effective method to reduce the child's probability of reconsulting with deterioration and can act as part of safetynetting strategies for parents. The implications for clinical practice are that the majority of children presenting with acute cough and respiratory symptoms in primary care are not at risk of hospitalisation, and antibiotics may not reduce the risk. If clinicians are considering an antibiotic, a delayed prescription may be preferable as it is likely to reduce reconsultation for deterioration.
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